Related Content
Will these 4 new drugs re-shape the market?
Get the latest in this quarter’s Drug Pipeline Insights Report.
5 questions: Optum Rx chief pharmacy officer
Michael Einodshofer addresses the risks, challenges and opportunities facing the industry.
Making sense of copay cards
How copay cards can disrupt your benefit strategy